Preclinical

SCOPE 2022

Bright ideas, new partnerships, and fun on tap at SCOPE 2022

26-Jan-2022 By Jenni Spinner

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

SCOPE 2022

SCOPE award salutes heroic innovation in clinical trial solutions

26-Jan-2022 By Jenni Spinner

One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.

Charles River joins with immunology lab on COVID-19 research

24-Jan-2022 By Jenni Spinner

The CRO's work with La Jolla Institute for Immunology, centered on a unique mouse model, is intended to increase understanding of how the COVID-19 virus operates.

Will new Facebook ad policy shake up clinical trial recruitment?

20-Jan-2022 By Jenni Spinner

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.

Pfizer: COVID-19 treatment shows promise against omicron variant

18-Jan-2022 By Jenni Spinner

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.

Vanderbilt discovery offers hope for colorectal cancer patients

17-Jan-2022 By Jenni Spinner

The researchers, in studying how polyps morph into colorectal cancer, have set a path for improved surveillance of the disease, harnessing precision medicine.

Pharma R&D investment report shows positive signs: Deloitte

14-Jan-2022 By Jenni Spinner

According to the company’s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

Managing QC lab data is important part of research equation: Veeva

13-Jan-2022 By Jenni Spinner

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

Sanofi extends its RWD-focused partnership with Evidation

10-Jan-2022 By Jenni Spinner

The collaboration will center on development of unique data sets, which could be used in helping promote better understanding of aspects of human health.

Stand Up To Cancer research initiative targets pancreatic cancer

10-Jan-2022 By Jenni Spinner

Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Clover Biopharmaceuticals begins construction of new R&D center in Shanghai

06-Jan-2022 By Rachel Arthur

Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.

Artificial intelligence could benefit all aspects of clinical trials: IQVIA

04-Jan-2022 By Jenni Spinner

An AI expert discusses progress in the field, gaps in understanding, and how predictive modeling and other advanced analytical tools could be put to use.

Purchases, pandemic, and potential treatments: 2021’s greatest hits

22-Dec-2021 By Jenni Spinner

OSP’s list of the year’s most-read stories shows readers are interested in M&A activities, new drug candidates, COVID-19 developments, and other hot news.

Bias in artificial intelligence impacts drug development: AiCure

20-Dec-2021 By Jenni Spinner

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.

Most oncologists think RWD vital to advancing cancer research: COTA

17-Dec-2021 By Jenni Spinner

The company has released a survey of cancer doctors; 83% of those polled believe real-world data is crucial to accelerating cancer research and treatment.

Abbott, Howard University join to boost research diversity

13-Dec-2021 By Jenni Spinner

The healthcare company has gifted $1m to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.

Time to take trial data analysis to the next level: ConcertAI

09-Dec-2021 By Jenni Spinner

A leader from the advanced data and artificial intelligence specialist suggests ways to advance data collection through new tools, techniques, and thinking.

Roquette plans to open doors of new US innovation center

08-Dec-2021 By Jenni Spinner

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

Is artificial intelligence the best tool for drug discovery?

07-Dec-2021 By Jenni Spinner

According to a leader from Cytoreason, AI isn’t necessarily the best or only tool suited to discover new and novel therapies—it might take a human touch.

People on the Move: December 2021

02-Dec-2021 By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

02-Dec-2021 By Rachel Arthur

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

Gain Therapeutics presents hopeful data for Parkinson’s, Gaucher treatment

29-Nov-2021 By Jenni Spinner

The biotech firm has presented data from a study that could offer hope to patients with Parkinson’s, Gaucher, Alzheimer’s and other neurodegenerative conditions.

Genetic testing offers powerful weapon for detecting breast cancer: Sema4

29-Nov-2021 By Jenni Spinner

A leader from Sema4, the health intelligence company, explains how progress in genetic testing has helped advance breast cancer detection and prevention.

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

25-Nov-2021 By Rachel Arthur

A new clinical trial of heterologous – or ‘mix-and-match’ – combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.

AstraZeneca opens new advanced therapeutics R&D facility in Cambridge

23-Nov-2021 By Jane Byrne

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

Industry veteran commits to improved patient solutions at CTMA

08-Nov-2021 By Jenni Spinner

After 30 years’ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.

Digital Medicine Society brings pharma firms together on new digital endpoint

02-Nov-2021 By Jenni Spinner

The group is collaborating with AbbVie, Janssen, Novartis, Pfizer, and UCB to help advance nocturnal scratch as a digital endpoint for atopic dermatitis.

Protodigm collaborates with research institute on heart disease dataset

02-Nov-2021 By Jenni Spinner

The company is joining with the Thrombosis Research Institute on the creation of a heart disease patient dataset to advance precision medicine development.

Global Genes partners to elevate equity for rare disease patients

25-Oct-2021 By Jenni Spinner

The advocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.

RWD from community registries adds long COVID understanding: IQVIA

25-Oct-2021 By Jenni Spinner

An epidemiologist from the healthcare data specialist offers perspective on how real-world data can help get to the heart of long-lasting COVID research.

UCI, Syntropy join forces on research/care data project

19-Oct-2021 By Jenni Spinner

The University of California at Irvine and the data firm will work on solutions that help integrate health data for both clinical trials and patient care.

COVID-19 lessons can apply to hepatitis treatments: Phesi

18-Oct-2021 By Jenni Spinner

According to the firm, infectious-disease research advancements could be applied to discovering treatments for millions of hepatitis patients globally.

AI-powered data specialist ScienceIO announces official launch

14-Oct-2021 By Jenni Spinner

The company has deployed with several healthcare firms, emerged from stealth, named a chief commercial officer, and landed investors backing the technology.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

‘Progress does not happen overnight’: Sanofi on evolution of medicine

14-Oct-2021 By Jenni Spinner

A leader from the pharmaceutical firm talks about some of the most impactful technologies and shares a number of notable advancements made by the company.

CDC turns to PointClickCare to gain insights from patient data

12-Oct-2021 By Jenni Spinner

The US agency plans to use the software firm’s Lighthouse technology to improve understanding of COVID-19 and other conditions in long-term care facilities.

CytoReason, Summit tap into AI on Japanese drug development effort

12-Oct-2021 By Jenni Spinner

The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.

Mastering data management can lead to improved outcomes: CitiusTech

11-Oct-2021 By Jenni Spinner

According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care.

Metrics make a difference in clinical research advancement: Advarra

07-Oct-2021 By Jenni Spinner

An expert from the IRB and study solutions firm explains how advanced analytics can lead to several benefits, including shortened trial startup timelines.

People on the Move: October 2021

07-Oct-2021 By Jenni Spinner

This month’s news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

Informatics useful in advancing personalized medicine: Washington University

05-Oct-2021 By Jenni Spinner

A representative from the school explains how tools like artificial intelligence and natural language processing can help elevate personalized medicine.

Making the most of trial data can benefit patients: Parexel

05-Oct-2021 By Jenni Spinner

An expert from the CRO explains the evolution of data technologies put to use in clinical studies and offers advice on how to best make them work in trials.

Patients want to see more health industry collaboration: survey

30-Sep-2021 By Jenni Spinner

A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.

Merck to acquire Acceleron Pharma, strengthening cardiovascular pipeline

30-Sep-2021 By Rachel Arthur

Merck (MSD outside the US and Canada) will acquire Acceleron in a deal worth around $11.5bn.

Real-world data use in trials can yield real benefits: Firma

27-Sep-2021 By Jenni Spinner

A leader from Firma Clinical Research advises that while using RWD can be daunting, putting the data to use can lead to a number of notable advantages.

Rare-disease initiative collaborators work to advance research innovation

16-Sep-2021 By Jenni Spinner

Stakeholders in the Rare Disease Cures Accelerator-Data and Analytics Platform initiative are partnering in hopes of bringing treatments to patients faster.

Tech Innovations: September 2021

16-Sep-2021 By Jenni Spinner

This month’s roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.

Gates Foundation, Exscientia enter $70m agreement to develop COVID-19 treatments

14-Sep-2021 By Jenni Spinner

The pharma tech firm has forged a four-year partnership with the foundation to develop antivirals for COVID-19 and other viruses with pandemic potential.

NIH offers $185m to further understanding of the human genome

13-Sep-2021 By Jenni Spinner

The US medical research agency plans to offer funding over five years through a newly launched consortium, expected to include 30 sites across the country.